Matches in Wikidata for { <http://www.wikidata.org/entity/Q37270040> ?p ?o ?g. }
- Q37270040 description "article científic" @default.
- Q37270040 description "article scientifique" @default.
- Q37270040 description "articolo scientifico" @default.
- Q37270040 description "artigo científico" @default.
- Q37270040 description "artículu científicu espublizáu en 2013" @default.
- Q37270040 description "bilimsel makale" @default.
- Q37270040 description "scientific article published on 26 March 2013" @default.
- Q37270040 description "vedecký článok" @default.
- Q37270040 description "vetenskaplig artikel" @default.
- Q37270040 description "videnskabelig artikel" @default.
- Q37270040 description "vědecký článek" @default.
- Q37270040 description "wetenschappelijk artikel" @default.
- Q37270040 description "wissenschaftlicher Artikel" @default.
- Q37270040 description "наукова стаття, опублікована в березні 2013" @default.
- Q37270040 description "научни чланак" @default.
- Q37270040 description "مقالة علمية نشرت في 26 مارس 2013" @default.
- Q37270040 name "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis" @default.
- Q37270040 name "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis" @default.
- Q37270040 name "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis." @default.
- Q37270040 type Item @default.
- Q37270040 label "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis" @default.
- Q37270040 label "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis" @default.
- Q37270040 label "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis." @default.
- Q37270040 prefLabel "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis" @default.
- Q37270040 prefLabel "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis" @default.
- Q37270040 prefLabel "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis." @default.
- Q37270040 P1433 Q37270040-211358A4-AF39-4198-A9B9-3DA1DB203CAE @default.
- Q37270040 P1476 Q37270040-D8091D05-E5F4-40C7-AE84-440A273047DC @default.
- Q37270040 P2093 Q37270040-24E9D04B-DB79-4CF9-8AC0-DE29E5035054 @default.
- Q37270040 P2093 Q37270040-3E5D57EB-F40F-457C-9D7B-96C6DD9716CB @default.
- Q37270040 P2093 Q37270040-3E9636DE-8029-4A4D-B2BD-25DB5D87A884 @default.
- Q37270040 P2093 Q37270040-41BBE131-AAC8-4B88-A5A2-CDE6A73AA5E0 @default.
- Q37270040 P2093 Q37270040-4B27588B-E75B-434B-AC3A-9DCD8467A2A3 @default.
- Q37270040 P2093 Q37270040-4C3F9705-60AE-4297-8949-904494D459FB @default.
- Q37270040 P2093 Q37270040-6B13BA0A-8AAD-4F8C-858A-6F904B68D7FB @default.
- Q37270040 P2093 Q37270040-AB1C8DE6-3FD0-4750-90A2-3D195D9CB58E @default.
- Q37270040 P2093 Q37270040-FDC82EC2-9379-4B2D-86EE-AC4B5442CD6A @default.
- Q37270040 P2860 Q37270040-05648DF5-3DC1-491C-9340-6844EF9D2A3C @default.
- Q37270040 P2860 Q37270040-0CC07398-5F61-4233-9271-80EF1F73CCFA @default.
- Q37270040 P2860 Q37270040-20E0B555-0E00-40D4-8E6F-19F82BE5CC26 @default.
- Q37270040 P2860 Q37270040-2C594764-91EB-42F0-B15A-839A5E25EDFF @default.
- Q37270040 P2860 Q37270040-37B33F23-167C-4328-8864-E55B12922F71 @default.
- Q37270040 P2860 Q37270040-38AC047C-A37E-42EC-8894-82F581A7075E @default.
- Q37270040 P2860 Q37270040-41DC6BAE-C11A-4617-8E1F-0FA2CFF20299 @default.
- Q37270040 P2860 Q37270040-48D8566A-304E-45F0-9043-370484328808 @default.
- Q37270040 P2860 Q37270040-4C5B1B43-39AA-477F-A652-3DAE06162282 @default.
- Q37270040 P2860 Q37270040-4FB17AFD-4864-4CA3-8258-DDFA8C4BB3CF @default.
- Q37270040 P2860 Q37270040-507A5F48-C722-4994-86E5-4149B31D49DB @default.
- Q37270040 P2860 Q37270040-5111B899-D117-4A13-A6FE-4265512D1868 @default.
- Q37270040 P2860 Q37270040-5677CB97-383B-4C1B-903D-9C07D7E4C99E @default.
- Q37270040 P2860 Q37270040-5C2BADD8-31AA-41E1-8C48-7314C91BF03C @default.
- Q37270040 P2860 Q37270040-881A9D2C-BB7A-4602-91BA-9166F9D69D1C @default.
- Q37270040 P2860 Q37270040-9FA590A7-FDD1-4FCE-B610-5B9DE3B7C2EF @default.
- Q37270040 P2860 Q37270040-AF9D1404-A93C-438A-AE0C-94F02CE6E379 @default.
- Q37270040 P2860 Q37270040-B3127B3F-F44E-458A-8EFA-23D4AE6BBA9C @default.
- Q37270040 P2860 Q37270040-BC3889AC-B3C8-425D-9CD6-95D9979A1E74 @default.
- Q37270040 P2860 Q37270040-C4DD0BE2-6929-4E58-A6E6-AC25CDB7FC61 @default.
- Q37270040 P2860 Q37270040-C5AB2E09-2124-4FC4-8FBB-130629EC37D3 @default.
- Q37270040 P2860 Q37270040-CD340078-3618-46EC-BA11-A9391978C3E2 @default.
- Q37270040 P2860 Q37270040-D514E9B0-E673-4968-A1AB-0069CD4BA335 @default.
- Q37270040 P2860 Q37270040-D5809210-9BA3-4003-9F3C-114ACBEBECC2 @default.
- Q37270040 P2860 Q37270040-D5E8B6EC-C526-4CC5-A9A3-6C3278F904D2 @default.
- Q37270040 P2860 Q37270040-DC534B2D-75B1-45D4-B471-534045D5A897 @default.
- Q37270040 P2860 Q37270040-EEFBF0AD-E10E-4131-A6D0-5BCB4D3CA4B9 @default.
- Q37270040 P2860 Q37270040-F422B882-9354-4634-B19D-C8EAA59CD3EF @default.
- Q37270040 P304 Q37270040-C6F7F99F-961E-411C-A804-0AB7D10936A0 @default.
- Q37270040 P31 Q37270040-A004A9DB-BFE1-4ECD-960F-99FCB71C00EC @default.
- Q37270040 P356 Q37270040-C78D4EC1-1245-43F5-B22E-3D36C4E73626 @default.
- Q37270040 P433 Q37270040-5A02D1DB-0D28-438A-ADBB-EFA21C1C561F @default.
- Q37270040 P478 Q37270040-55BE86E9-C589-476B-BE28-2ACD8AEF6A1B @default.
- Q37270040 P50 Q37270040-94ECF606-4828-4724-BC11-B6F3C429FA75 @default.
- Q37270040 P577 Q37270040-601C8BA0-E0C7-41D5-83E2-21C4B78CC84E @default.
- Q37270040 P698 Q37270040-56E6930D-53E7-4BB1-8253-D460C5696AEF @default.
- Q37270040 P921 Q37270040-0C013C02-6112-420D-8E21-53D282EF4865 @default.
- Q37270040 P932 Q37270040-6737CD8B-74F5-48A5-ACCF-51303BA6C59C @default.
- Q37270040 P356 1940-6207.CAPR-12-0322 @default.
- Q37270040 P698 23531447 @default.
- Q37270040 P1433 Q2665103 @default.
- Q37270040 P1476 "Effect of intermittent dosing regimens of erlotinib on methylnitrosourea-induced mammary carcinogenesis" @default.
- Q37270040 P2093 "Chris Tucker" @default.
- Q37270040 P2093 "Clinton J Grubbs" @default.
- Q37270040 P2093 "Eva Szabo" @default.
- Q37270040 P2093 "Holly L Nicastro" @default.
- Q37270040 P2093 "Kenneth K Iwata" @default.
- Q37270040 P2093 "M Margaret Juliana" @default.
- Q37270040 P2093 "Ronald A Lubet" @default.
- Q37270040 P2093 "Stanley C Gill" @default.
- Q37270040 P2093 "Vernon E Steele" @default.
- Q37270040 P2860 Q28293442 @default.
- Q37270040 P2860 Q34992235 @default.
- Q37270040 P2860 Q35007782 @default.
- Q37270040 P2860 Q35552069 @default.
- Q37270040 P2860 Q35570245 @default.
- Q37270040 P2860 Q36145430 @default.
- Q37270040 P2860 Q37357287 @default.
- Q37270040 P2860 Q40133809 @default.
- Q37270040 P2860 Q42973648 @default.
- Q37270040 P2860 Q43136784 @default.
- Q37270040 P2860 Q43279359 @default.
- Q37270040 P2860 Q43658492 @default.